Biophotonic Solutions closes $1M funding round

Automated laser pulse compression technology developer Biophotonic Solutions Inc. (BSI) has closed a $1 million Series A funding round led by the Michigan Angel Fund.

Automated laser pulse compression technology developer Biophotonic Solutions Inc. (BSI; East Lansing, MI) has closed a $1 million Series A funding round led by the Michigan Angel Fund.

The funding round enables the company to pursue OEM business in microscopy, semiconductor processing, and the development of cost-effective ultrafast lasers with adaptive capabilities, says Kiyomi Monro, BSI's CEO.

Typically used for scientific research, ultrafast lasers producing pulses in the multi-femtosecond range offer significant advantages for many commercial applications. However, these lasers are expensive, challenging to implement, and demand manual tweaking from a laser expert to fine-tune their output. The company's proprietary multiphoton intrapulse interference phase scan (MIIPS) technology provides automated measurement and compression of ultrafast laser pulses, automatically delivering optimized laser light to the target. Thanks to this new level of autonomous laser output consistency and ease of use, MIIPS technology may ultimately enable scalable and cost-effective femtosecond laser deployment in a wide range of industrial and medical settings.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

More in Microscopy